Review



annexin fitc 1 binding buffer  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    R&D Systems annexin fitc 1 binding buffer
    Annexin Fitc 1 Binding Buffer, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 298 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/annexin+fitc+1+binding+buffer/10__1158_slash_0008___5472__can___23___2994-71-43-47?v=R%26D+Systems
    Average 96 stars, based on 298 article reviews
    annexin fitc 1 binding buffer - by Bioz Stars, 2026-08
    96/100 stars

    Images



    Similar Products

    90
    Thermo Fisher 1× annexin v-fitc binding buffer
    Quantification of viable HCT116-DoxR tumor cells, in early apoptosis, late apoptosis, and necrosis marked with <t>Annexin</t> V-FITC and PI, was performed by flow cytometry after exposure to Cu1a and Cu1b complexes for 48 h at their IC 50 concentrations. Three controls (DMSO 0.1%, Cis, and Dox) were also included for comparison. The presented results are expressed as mean ± SEM obtained from at least two independent biological assays. To assess the statistical significance of these results compared to the control group treated with DMSO, the one-way ANOVA method was used (* p ≤ 0.05; ** p ≤ 0.005; *** p ≤ 0.0005; **** p ≤ 0.0001).
    1× Annexin V Fitc Binding Buffer, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/annexin+fitc+1+binding+buffer/pmc11571215-468-31-49?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    1× annexin v-fitc binding buffer - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    98
    Elabscience Biotechnology annexin v 1× binding buffer
    Quantification of viable HCT116-DoxR tumor cells, in early apoptosis, late apoptosis, and necrosis marked with <t>Annexin</t> V-FITC and PI, was performed by flow cytometry after exposure to Cu1a and Cu1b complexes for 48 h at their IC 50 concentrations. Three controls (DMSO 0.1%, Cis, and Dox) were also included for comparison. The presented results are expressed as mean ± SEM obtained from at least two independent biological assays. To assess the statistical significance of these results compared to the control group treated with DMSO, the one-way ANOVA method was used (* p ≤ 0.05; ** p ≤ 0.005; *** p ≤ 0.0005; **** p ≤ 0.0001).
    Annexin V 1× Binding Buffer, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/annexin+fitc+1+binding+buffer/pm38588876-86-18-26?v=Elabscience+Biotechnology
    Average 98 stars, based on 1 article reviews
    annexin v 1× binding buffer - by Bioz Stars, 2026-08
    98/100 stars
      Buy from Supplier

    96
    R&D Systems annexin fitc 1 binding buffer
    Quantification of viable HCT116-DoxR tumor cells, in early apoptosis, late apoptosis, and necrosis marked with <t>Annexin</t> V-FITC and PI, was performed by flow cytometry after exposure to Cu1a and Cu1b complexes for 48 h at their IC 50 concentrations. Three controls (DMSO 0.1%, Cis, and Dox) were also included for comparison. The presented results are expressed as mean ± SEM obtained from at least two independent biological assays. To assess the statistical significance of these results compared to the control group treated with DMSO, the one-way ANOVA method was used (* p ≤ 0.05; ** p ≤ 0.005; *** p ≤ 0.0005; **** p ≤ 0.0001).
    Annexin Fitc 1 Binding Buffer, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/annexin+fitc+1+binding+buffer/10__1158_slash_0008___5472__can___23___2994-71-43-47?v=R%26D+Systems
    Average 96 stars, based on 1 article reviews
    annexin fitc 1 binding buffer - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    90
    Becton Dickinson 1× annexin v binding buffer from the fitc annexin v apoptosis detection kit
    Characterization of islet-lncRNAs in islets cultured with glucose and with and without cytokines. (A) Changes in expression of islet-lncRNA, genes related to β-cell secretion (insulin, PCSK1), related to apoptosis (NFKβ1, CASP3, BAX, and BCL2), and related to ER stress (DDIT3 and HSPA5) in response to glucose stimulation. Data presented as mean ± SE. ***Paired t -test, p < 0.05. (B) Images of immunohistochemistry coupled with TUNEL assays on the islets cultured in vitro with cytokines (lower panel) and control (upper panel). DNA was stained as blue with DAPI, TUNEL + cells were detected as green, and insulin + cells/β cells were identified red. Apoptotic β cells are indicated as white arrows. (C) Percentage of apoptotic TUNEL + β cells in total β cells per islets cultured with and without cytokines from three donors (paired t -test, p < 0.05). (D) Determination of the effect of cytokines on apoptosis of islet cells in flow cytometry assay. Dot plots demonstrating separation of dissociated islet cells into early apoptotic cells in the lower right quadrant (Q3) (Annexin V +/ PI - ), necrotic cells in the upper right quadrant (Q2) (Annexin V + and PI + ), and late apoptotic cells in upper left quadrant (Q1) (Annexin V - and PI + ). Value in percentage of lower left quadrant (Q1) represents viable cells that were not stained with <t>Annexin-V</t> or PI. (E) Fold changes of lncRNAs in the cytokine-treated islets compared to that of control islets. Data presented as mean ± SE. *** Paired t -test, p < 0.05.
    1× Annexin V Binding Buffer From The Fitc Annexin V Apoptosis Detection Kit, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/annexin+fitc+1+binding+buffer/pmc10646418-170-20-32?v=Becton+Dickinson
    Average 90 stars, based on 1 article reviews
    1× annexin v binding buffer from the fitc annexin v apoptosis detection kit - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    Shanghai Yuanye Biotechnology 1 ml of ice annexin v-fitc binding buffer
    Characterization of islet-lncRNAs in islets cultured with glucose and with and without cytokines. (A) Changes in expression of islet-lncRNA, genes related to β-cell secretion (insulin, PCSK1), related to apoptosis (NFKβ1, CASP3, BAX, and BCL2), and related to ER stress (DDIT3 and HSPA5) in response to glucose stimulation. Data presented as mean ± SE. ***Paired t -test, p < 0.05. (B) Images of immunohistochemistry coupled with TUNEL assays on the islets cultured in vitro with cytokines (lower panel) and control (upper panel). DNA was stained as blue with DAPI, TUNEL + cells were detected as green, and insulin + cells/β cells were identified red. Apoptotic β cells are indicated as white arrows. (C) Percentage of apoptotic TUNEL + β cells in total β cells per islets cultured with and without cytokines from three donors (paired t -test, p < 0.05). (D) Determination of the effect of cytokines on apoptosis of islet cells in flow cytometry assay. Dot plots demonstrating separation of dissociated islet cells into early apoptotic cells in the lower right quadrant (Q3) (Annexin V +/ PI - ), necrotic cells in the upper right quadrant (Q2) (Annexin V + and PI + ), and late apoptotic cells in upper left quadrant (Q1) (Annexin V - and PI + ). Value in percentage of lower left quadrant (Q1) represents viable cells that were not stained with <t>Annexin-V</t> or PI. (E) Fold changes of lncRNAs in the cytokine-treated islets compared to that of control islets. Data presented as mean ± SE. *** Paired t -test, p < 0.05.
    1 Ml Of Ice Annexin V Fitc Binding Buffer, supplied by Shanghai Yuanye Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/annexin+fitc+1+binding+buffer/pmc08390158-55-11-28?v=Shanghai+Yuanye+Biotechnology
    Average 90 stars, based on 1 article reviews
    1 ml of ice annexin v-fitc binding buffer - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson 1× binding buffer from the fitc annexin v apoptosis detection kit
    Characterization of islet-lncRNAs in islets cultured with glucose and with and without cytokines. (A) Changes in expression of islet-lncRNA, genes related to β-cell secretion (insulin, PCSK1), related to apoptosis (NFKβ1, CASP3, BAX, and BCL2), and related to ER stress (DDIT3 and HSPA5) in response to glucose stimulation. Data presented as mean ± SE. ***Paired t -test, p < 0.05. (B) Images of immunohistochemistry coupled with TUNEL assays on the islets cultured in vitro with cytokines (lower panel) and control (upper panel). DNA was stained as blue with DAPI, TUNEL + cells were detected as green, and insulin + cells/β cells were identified red. Apoptotic β cells are indicated as white arrows. (C) Percentage of apoptotic TUNEL + β cells in total β cells per islets cultured with and without cytokines from three donors (paired t -test, p < 0.05). (D) Determination of the effect of cytokines on apoptosis of islet cells in flow cytometry assay. Dot plots demonstrating separation of dissociated islet cells into early apoptotic cells in the lower right quadrant (Q3) (Annexin V +/ PI - ), necrotic cells in the upper right quadrant (Q2) (Annexin V + and PI + ), and late apoptotic cells in upper left quadrant (Q1) (Annexin V - and PI + ). Value in percentage of lower left quadrant (Q1) represents viable cells that were not stained with <t>Annexin-V</t> or PI. (E) Fold changes of lncRNAs in the cytokine-treated islets compared to that of control islets. Data presented as mean ± SE. *** Paired t -test, p < 0.05.
    1× Binding Buffer From The Fitc Annexin V Apoptosis Detection Kit, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/annexin+fitc+1+binding+buffer/pm36242003-301-6-12?v=Becton+Dickinson
    Average 90 stars, based on 1 article reviews
    1× binding buffer from the fitc annexin v apoptosis detection kit - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    Yeasen Biotechnology 100 µl 1 × binding buffer (annexin v-fitc/pi apoptosis detection kit
    a Kaplan–Meier plots show significant differences between the sensitive group (S) and non-sensitive group (NS) in overall survival (OS) (upper) and progression-free survival (PFS) (bottom) in the HER2 subcohort (two-sided log rank test). b Boxplot showing the ERBB2 expression in HSG ( n = 32) and HNSG ( n = 37) (two-sided Wilcoxon rank-sum test) (upper). Boxplots show median (central line), upper and lower quartiles (box limits), 1.5× interquartile range (whiskers). Cox analysis (two-sided Cox test) of ERBB2 with OS (bottom). c Heatmap showing the abundance of differentially expressed proteins in HSG and HNSG. d Pathway alterations in HSG and HNSG (two-sided Fisher’s exact test). e The GSEA enrichment analysis of ECM in HER2 subcohort (Nominal P value, calculated as Phenotype-based permutation test). The survival analysis of ssGSEA ECM pathway score with OS in HER2 subcohort (two-sided log rank test). f Heatmap illustrating the abundance of ECM proteins in HER2 subcohort and five gastric cancer cells (two-sided Wilcoxon rank-sum test). g , h Left panel: Correlation of ECM pathway score ( g ) and PI3K-AKT pathway score ( h ) with its downstream pathway assessed by ssGSEA (two-sided Pearson’s correlation test). Right panel: Heatmap illustrating the protein abundance of PI3K-AKT pathway ( g ) and <t>apoptosis</t> ( h ) related proteins (two-sided Wilcoxon rank-sum test). i Dose-response curves of NCI-N87 cells after 72-h treatments with buparlisib (BUP), trastuzumab (TRA), and combination of trastuzumab and buparlisib with a ratio of 1:1. IC50, half-maximal inhibitory concentration. The comparison of IC50 values of different therapies (two-sided Student’s t test). Bars represent the mean of n = 3 independent experiments with error bars indicating SD. j Diagram showing the potential mechanism of resistance to anti-HER2 targeted therapy. k The decision-making strategy for the GC therapy. * P < 0.05 is considered statistically significant. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Source data are provided as a Source Data file.
    100 µl 1 × Binding Buffer (Annexin V Fitc/Pi Apoptosis Detection Kit, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/annexin+fitc+1+binding+buffer/pmc09522856-645-16-21?v=Yeasen+Biotechnology
    Average 90 stars, based on 1 article reviews
    100 µl 1 × binding buffer (annexin v-fitc/pi apoptosis detection kit - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    Beyotime 1× annexin v-fitc binding buffer
    a Kaplan–Meier plots show significant differences between the sensitive group (S) and non-sensitive group (NS) in overall survival (OS) (upper) and progression-free survival (PFS) (bottom) in the HER2 subcohort (two-sided log rank test). b Boxplot showing the ERBB2 expression in HSG ( n = 32) and HNSG ( n = 37) (two-sided Wilcoxon rank-sum test) (upper). Boxplots show median (central line), upper and lower quartiles (box limits), 1.5× interquartile range (whiskers). Cox analysis (two-sided Cox test) of ERBB2 with OS (bottom). c Heatmap showing the abundance of differentially expressed proteins in HSG and HNSG. d Pathway alterations in HSG and HNSG (two-sided Fisher’s exact test). e The GSEA enrichment analysis of ECM in HER2 subcohort (Nominal P value, calculated as Phenotype-based permutation test). The survival analysis of ssGSEA ECM pathway score with OS in HER2 subcohort (two-sided log rank test). f Heatmap illustrating the abundance of ECM proteins in HER2 subcohort and five gastric cancer cells (two-sided Wilcoxon rank-sum test). g , h Left panel: Correlation of ECM pathway score ( g ) and PI3K-AKT pathway score ( h ) with its downstream pathway assessed by ssGSEA (two-sided Pearson’s correlation test). Right panel: Heatmap illustrating the protein abundance of PI3K-AKT pathway ( g ) and <t>apoptosis</t> ( h ) related proteins (two-sided Wilcoxon rank-sum test). i Dose-response curves of NCI-N87 cells after 72-h treatments with buparlisib (BUP), trastuzumab (TRA), and combination of trastuzumab and buparlisib with a ratio of 1:1. IC50, half-maximal inhibitory concentration. The comparison of IC50 values of different therapies (two-sided Student’s t test). Bars represent the mean of n = 3 independent experiments with error bars indicating SD. j Diagram showing the potential mechanism of resistance to anti-HER2 targeted therapy. k The decision-making strategy for the GC therapy. * P < 0.05 is considered statistically significant. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Source data are provided as a Source Data file.
    1× Annexin V Fitc Binding Buffer, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/annexin+fitc+1+binding+buffer/pm35209807-46-9-15?v=Beyotime
    Average 90 stars, based on 1 article reviews
    1× annexin v-fitc binding buffer - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    Partec annexin v-fitc binding buffer (190 ml; 1 v)
    a Kaplan–Meier plots show significant differences between the sensitive group (S) and non-sensitive group (NS) in overall survival (OS) (upper) and progression-free survival (PFS) (bottom) in the HER2 subcohort (two-sided log rank test). b Boxplot showing the ERBB2 expression in HSG ( n = 32) and HNSG ( n = 37) (two-sided Wilcoxon rank-sum test) (upper). Boxplots show median (central line), upper and lower quartiles (box limits), 1.5× interquartile range (whiskers). Cox analysis (two-sided Cox test) of ERBB2 with OS (bottom). c Heatmap showing the abundance of differentially expressed proteins in HSG and HNSG. d Pathway alterations in HSG and HNSG (two-sided Fisher’s exact test). e The GSEA enrichment analysis of ECM in HER2 subcohort (Nominal P value, calculated as Phenotype-based permutation test). The survival analysis of ssGSEA ECM pathway score with OS in HER2 subcohort (two-sided log rank test). f Heatmap illustrating the abundance of ECM proteins in HER2 subcohort and five gastric cancer cells (two-sided Wilcoxon rank-sum test). g , h Left panel: Correlation of ECM pathway score ( g ) and PI3K-AKT pathway score ( h ) with its downstream pathway assessed by ssGSEA (two-sided Pearson’s correlation test). Right panel: Heatmap illustrating the protein abundance of PI3K-AKT pathway ( g ) and <t>apoptosis</t> ( h ) related proteins (two-sided Wilcoxon rank-sum test). i Dose-response curves of NCI-N87 cells after 72-h treatments with buparlisib (BUP), trastuzumab (TRA), and combination of trastuzumab and buparlisib with a ratio of 1:1. IC50, half-maximal inhibitory concentration. The comparison of IC50 values of different therapies (two-sided Student’s t test). Bars represent the mean of n = 3 independent experiments with error bars indicating SD. j Diagram showing the potential mechanism of resistance to anti-HER2 targeted therapy. k The decision-making strategy for the GC therapy. * P < 0.05 is considered statistically significant. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Source data are provided as a Source Data file.
    Annexin V Fitc Binding Buffer (190 Ml; 1 V), supplied by Partec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/annexin+fitc+1+binding+buffer/pm30506622-134-14-42?v=Partec
    Average 90 stars, based on 1 article reviews
    annexin v-fitc binding buffer (190 ml; 1 v) - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    97
    Vazyme Biotech Co 1×annexin v binding buffer
    a Kaplan–Meier plots show significant differences between the sensitive group (S) and non-sensitive group (NS) in overall survival (OS) (upper) and progression-free survival (PFS) (bottom) in the HER2 subcohort (two-sided log rank test). b Boxplot showing the ERBB2 expression in HSG ( n = 32) and HNSG ( n = 37) (two-sided Wilcoxon rank-sum test) (upper). Boxplots show median (central line), upper and lower quartiles (box limits), 1.5× interquartile range (whiskers). Cox analysis (two-sided Cox test) of ERBB2 with OS (bottom). c Heatmap showing the abundance of differentially expressed proteins in HSG and HNSG. d Pathway alterations in HSG and HNSG (two-sided Fisher’s exact test). e The GSEA enrichment analysis of ECM in HER2 subcohort (Nominal P value, calculated as Phenotype-based permutation test). The survival analysis of ssGSEA ECM pathway score with OS in HER2 subcohort (two-sided log rank test). f Heatmap illustrating the abundance of ECM proteins in HER2 subcohort and five gastric cancer cells (two-sided Wilcoxon rank-sum test). g , h Left panel: Correlation of ECM pathway score ( g ) and PI3K-AKT pathway score ( h ) with its downstream pathway assessed by ssGSEA (two-sided Pearson’s correlation test). Right panel: Heatmap illustrating the protein abundance of PI3K-AKT pathway ( g ) and <t>apoptosis</t> ( h ) related proteins (two-sided Wilcoxon rank-sum test). i Dose-response curves of NCI-N87 cells after 72-h treatments with buparlisib (BUP), trastuzumab (TRA), and combination of trastuzumab and buparlisib with a ratio of 1:1. IC50, half-maximal inhibitory concentration. The comparison of IC50 values of different therapies (two-sided Student’s t test). Bars represent the mean of n = 3 independent experiments with error bars indicating SD. j Diagram showing the potential mechanism of resistance to anti-HER2 targeted therapy. k The decision-making strategy for the GC therapy. * P < 0.05 is considered statistically significant. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Source data are provided as a Source Data file.
    1×Annexin V Binding Buffer, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/annexin+fitc+1+binding+buffer/pm26616010-79-49-58?v=Vazyme+Biotech+Co
    Average 97 stars, based on 1 article reviews
    1×annexin v binding buffer - by Bioz Stars, 2026-08
    97/100 stars
      Buy from Supplier

    Image Search Results


    Quantification of viable HCT116-DoxR tumor cells, in early apoptosis, late apoptosis, and necrosis marked with Annexin V-FITC and PI, was performed by flow cytometry after exposure to Cu1a and Cu1b complexes for 48 h at their IC 50 concentrations. Three controls (DMSO 0.1%, Cis, and Dox) were also included for comparison. The presented results are expressed as mean ± SEM obtained from at least two independent biological assays. To assess the statistical significance of these results compared to the control group treated with DMSO, the one-way ANOVA method was used (* p ≤ 0.05; ** p ≤ 0.005; *** p ≤ 0.0005; **** p ≤ 0.0001).

    Journal: Journal of Medicinal Chemistry

    Article Title: Optimization of Antiproliferative Properties of Triimine Copper(II) Complexes

    doi: 10.1021/acs.jmedchem.4c01806

    Figure Lengend Snippet: Quantification of viable HCT116-DoxR tumor cells, in early apoptosis, late apoptosis, and necrosis marked with Annexin V-FITC and PI, was performed by flow cytometry after exposure to Cu1a and Cu1b complexes for 48 h at their IC 50 concentrations. Three controls (DMSO 0.1%, Cis, and Dox) were also included for comparison. The presented results are expressed as mean ± SEM obtained from at least two independent biological assays. To assess the statistical significance of these results compared to the control group treated with DMSO, the one-way ANOVA method was used (* p ≤ 0.05; ** p ≤ 0.005; *** p ≤ 0.0005; **** p ≤ 0.0001).

    Article Snippet: Subsequently, the samples were incubated at room temperature (RT) with Alexa Fluor 488 annexin V and 100 μg/mL of propidium iodide (PI) in the dark for 15 min. After incubation, 1× Annexin V-FITC binding buffer was added and the samples were analyzed using an Attune Acoustic Focusing Flow Cytometer (Life Technologies, Carlsbad, USA).

    Techniques: Flow Cytometry, Comparison, Control

    Characterization of islet-lncRNAs in islets cultured with glucose and with and without cytokines. (A) Changes in expression of islet-lncRNA, genes related to β-cell secretion (insulin, PCSK1), related to apoptosis (NFKβ1, CASP3, BAX, and BCL2), and related to ER stress (DDIT3 and HSPA5) in response to glucose stimulation. Data presented as mean ± SE. ***Paired t -test, p < 0.05. (B) Images of immunohistochemistry coupled with TUNEL assays on the islets cultured in vitro with cytokines (lower panel) and control (upper panel). DNA was stained as blue with DAPI, TUNEL + cells were detected as green, and insulin + cells/β cells were identified red. Apoptotic β cells are indicated as white arrows. (C) Percentage of apoptotic TUNEL + β cells in total β cells per islets cultured with and without cytokines from three donors (paired t -test, p < 0.05). (D) Determination of the effect of cytokines on apoptosis of islet cells in flow cytometry assay. Dot plots demonstrating separation of dissociated islet cells into early apoptotic cells in the lower right quadrant (Q3) (Annexin V +/ PI - ), necrotic cells in the upper right quadrant (Q2) (Annexin V + and PI + ), and late apoptotic cells in upper left quadrant (Q1) (Annexin V - and PI + ). Value in percentage of lower left quadrant (Q1) represents viable cells that were not stained with Annexin-V or PI. (E) Fold changes of lncRNAs in the cytokine-treated islets compared to that of control islets. Data presented as mean ± SE. *** Paired t -test, p < 0.05.

    Journal: Frontiers in Endocrinology

    Article Title: Exploring lncRNAs associated with human pancreatic islet cell death induced by transfer of adoptive lymphocytes in a humanized mouse model

    doi: 10.3389/fendo.2023.1244688

    Figure Lengend Snippet: Characterization of islet-lncRNAs in islets cultured with glucose and with and without cytokines. (A) Changes in expression of islet-lncRNA, genes related to β-cell secretion (insulin, PCSK1), related to apoptosis (NFKβ1, CASP3, BAX, and BCL2), and related to ER stress (DDIT3 and HSPA5) in response to glucose stimulation. Data presented as mean ± SE. ***Paired t -test, p < 0.05. (B) Images of immunohistochemistry coupled with TUNEL assays on the islets cultured in vitro with cytokines (lower panel) and control (upper panel). DNA was stained as blue with DAPI, TUNEL + cells were detected as green, and insulin + cells/β cells were identified red. Apoptotic β cells are indicated as white arrows. (C) Percentage of apoptotic TUNEL + β cells in total β cells per islets cultured with and without cytokines from three donors (paired t -test, p < 0.05). (D) Determination of the effect of cytokines on apoptosis of islet cells in flow cytometry assay. Dot plots demonstrating separation of dissociated islet cells into early apoptotic cells in the lower right quadrant (Q3) (Annexin V +/ PI - ), necrotic cells in the upper right quadrant (Q2) (Annexin V + and PI + ), and late apoptotic cells in upper left quadrant (Q1) (Annexin V - and PI + ). Value in percentage of lower left quadrant (Q1) represents viable cells that were not stained with Annexin-V or PI. (E) Fold changes of lncRNAs in the cytokine-treated islets compared to that of control islets. Data presented as mean ± SE. *** Paired t -test, p < 0.05.

    Article Snippet: Dissociated cells with media were filtered through a cell strainer (35 μm), washed twice with PBS, and resuspended in 1× Annexin V Binding Buffer from the FITC Annexin V Apoptosis Detection kit (BD Biosciences) in a concentration of 1.0 × 10 6 cells/100 μL.

    Techniques: Cell Culture, Expressing, Immunohistochemistry, TUNEL Assay, In Vitro, Staining, Flow Cytometry

    Staining of exosomes and detection of lncRNA in exosomes in response to cytokines. (A) Images of exosomes precipitated from culture media of cytokine-treated islets (lower panel) and from control islets (upper panel). DNA was stained as blue with DAPI, Annexin-V was detected as green, and the phospholipid bilayer membrane of exosomes was stained as red. Scale bars represent 1 µm. (B) A hierarchically clustered heatmap of the relative expression of islet-lncRNAs in the exosomes precipitated from islets (from three donors) cultured with and without cytokines. Treatment numbers 1, 2, and 3 represent the islets from donors 1, 2, and 3, respectively.

    Journal: Frontiers in Endocrinology

    Article Title: Exploring lncRNAs associated with human pancreatic islet cell death induced by transfer of adoptive lymphocytes in a humanized mouse model

    doi: 10.3389/fendo.2023.1244688

    Figure Lengend Snippet: Staining of exosomes and detection of lncRNA in exosomes in response to cytokines. (A) Images of exosomes precipitated from culture media of cytokine-treated islets (lower panel) and from control islets (upper panel). DNA was stained as blue with DAPI, Annexin-V was detected as green, and the phospholipid bilayer membrane of exosomes was stained as red. Scale bars represent 1 µm. (B) A hierarchically clustered heatmap of the relative expression of islet-lncRNAs in the exosomes precipitated from islets (from three donors) cultured with and without cytokines. Treatment numbers 1, 2, and 3 represent the islets from donors 1, 2, and 3, respectively.

    Article Snippet: Dissociated cells with media were filtered through a cell strainer (35 μm), washed twice with PBS, and resuspended in 1× Annexin V Binding Buffer from the FITC Annexin V Apoptosis Detection kit (BD Biosciences) in a concentration of 1.0 × 10 6 cells/100 μL.

    Techniques: Staining, Membrane, Expressing, Cell Culture

    a Kaplan–Meier plots show significant differences between the sensitive group (S) and non-sensitive group (NS) in overall survival (OS) (upper) and progression-free survival (PFS) (bottom) in the HER2 subcohort (two-sided log rank test). b Boxplot showing the ERBB2 expression in HSG ( n = 32) and HNSG ( n = 37) (two-sided Wilcoxon rank-sum test) (upper). Boxplots show median (central line), upper and lower quartiles (box limits), 1.5× interquartile range (whiskers). Cox analysis (two-sided Cox test) of ERBB2 with OS (bottom). c Heatmap showing the abundance of differentially expressed proteins in HSG and HNSG. d Pathway alterations in HSG and HNSG (two-sided Fisher’s exact test). e The GSEA enrichment analysis of ECM in HER2 subcohort (Nominal P value, calculated as Phenotype-based permutation test). The survival analysis of ssGSEA ECM pathway score with OS in HER2 subcohort (two-sided log rank test). f Heatmap illustrating the abundance of ECM proteins in HER2 subcohort and five gastric cancer cells (two-sided Wilcoxon rank-sum test). g , h Left panel: Correlation of ECM pathway score ( g ) and PI3K-AKT pathway score ( h ) with its downstream pathway assessed by ssGSEA (two-sided Pearson’s correlation test). Right panel: Heatmap illustrating the protein abundance of PI3K-AKT pathway ( g ) and apoptosis ( h ) related proteins (two-sided Wilcoxon rank-sum test). i Dose-response curves of NCI-N87 cells after 72-h treatments with buparlisib (BUP), trastuzumab (TRA), and combination of trastuzumab and buparlisib with a ratio of 1:1. IC50, half-maximal inhibitory concentration. The comparison of IC50 values of different therapies (two-sided Student’s t test). Bars represent the mean of n = 3 independent experiments with error bars indicating SD. j Diagram showing the potential mechanism of resistance to anti-HER2 targeted therapy. k The decision-making strategy for the GC therapy. * P < 0.05 is considered statistically significant. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies

    doi: 10.1038/s41467-022-33282-0

    Figure Lengend Snippet: a Kaplan–Meier plots show significant differences between the sensitive group (S) and non-sensitive group (NS) in overall survival (OS) (upper) and progression-free survival (PFS) (bottom) in the HER2 subcohort (two-sided log rank test). b Boxplot showing the ERBB2 expression in HSG ( n = 32) and HNSG ( n = 37) (two-sided Wilcoxon rank-sum test) (upper). Boxplots show median (central line), upper and lower quartiles (box limits), 1.5× interquartile range (whiskers). Cox analysis (two-sided Cox test) of ERBB2 with OS (bottom). c Heatmap showing the abundance of differentially expressed proteins in HSG and HNSG. d Pathway alterations in HSG and HNSG (two-sided Fisher’s exact test). e The GSEA enrichment analysis of ECM in HER2 subcohort (Nominal P value, calculated as Phenotype-based permutation test). The survival analysis of ssGSEA ECM pathway score with OS in HER2 subcohort (two-sided log rank test). f Heatmap illustrating the abundance of ECM proteins in HER2 subcohort and five gastric cancer cells (two-sided Wilcoxon rank-sum test). g , h Left panel: Correlation of ECM pathway score ( g ) and PI3K-AKT pathway score ( h ) with its downstream pathway assessed by ssGSEA (two-sided Pearson’s correlation test). Right panel: Heatmap illustrating the protein abundance of PI3K-AKT pathway ( g ) and apoptosis ( h ) related proteins (two-sided Wilcoxon rank-sum test). i Dose-response curves of NCI-N87 cells after 72-h treatments with buparlisib (BUP), trastuzumab (TRA), and combination of trastuzumab and buparlisib with a ratio of 1:1. IC50, half-maximal inhibitory concentration. The comparison of IC50 values of different therapies (two-sided Student’s t test). Bars represent the mean of n = 3 independent experiments with error bars indicating SD. j Diagram showing the potential mechanism of resistance to anti-HER2 targeted therapy. k The decision-making strategy for the GC therapy. * P < 0.05 is considered statistically significant. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Source data are provided as a Source Data file.

    Article Snippet: After two washes with cold PBS, cells were resuspended in 100 μL 1 × Binding Buffer (Annexin V-FITC/PI Apoptosis Detection Kit, YEASEN, Shanghai, China).

    Techniques: Expressing, Quantitative Proteomics, Concentration Assay, Comparison